Biomarker identification and pathway analysis by serum metabolomics of childhood acute lymphoblastic leukemia

Metabolomics can be used to analyze the metabolic activity of ALL patients compared to healthy controls. The data we provide here suggest that glycerophospholipid metabolism may be a key mechanism underlying disease progression and development.